Oragenics, Inc.
OGEN
$0.183
$0.0084.57%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -84.92% | 14.24% | -54.81% | -60.34% | 682.07% |
| Gross Profit | 84.92% | -15.37% | 54.51% | 59.93% | -682.07% |
| SG&A Expenses | -3.65% | 16.93% | 25.40% | 43.82% | 97.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -73.78% | 15.96% | -26.15% | -15.80% | 456.55% |
| Operating Income | 73.78% | -16.37% | 25.84% | 15.31% | -456.55% |
| Income Before Tax | 73.73% | -22.36% | 24.44% | 13.85% | -469.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 73.73% | -22.36% | 24.44% | 13.85% | -469.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 73.73% | -22.36% | 24.44% | 13.85% | -469.67% |
| EBIT | 73.78% | -16.37% | 25.84% | 15.31% | -456.55% |
| EBITDA | 73.83% | -16.30% | 25.78% | 15.21% | -459.74% |
| EPS Basic | 94.29% | 55.84% | 66.22% | 50.28% | -386.44% |
| Normalized Basic EPS | 94.29% | 55.84% | 66.22% | 50.29% | -386.39% |
| EPS Diluted | 94.29% | 55.84% | 66.22% | 50.28% | -386.44% |
| Normalized Diluted EPS | 94.29% | 55.84% | 66.22% | 50.29% | -386.39% |
| Average Basic Shares Outstanding | 360.12% | 177.07% | 123.68% | 73.28% | 17.11% |
| Average Diluted Shares Outstanding | 360.12% | 177.07% | 123.68% | 73.28% | 17.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |